Literature DB >> 21670265

Polycystin-2 and phosphodiesterase 4C are components of a ciliary A-kinase anchoring protein complex that is disrupted in cystic kidney diseases.

Yun-Hee Choi1, Akira Suzuki, Sachin Hajarnis, Zhendong Ma, Hannah C Chapin, Michael J Caplan, Marco Pontoglio, Stefan Somlo, Peter Igarashi.   

Abstract

Polycystic kidney disease (PKD) is a genetic disorder that is characterized by cyst formation in kidney tubules. PKD arises from abnormalities of the primary cilium, a sensory organelle located on the cell surface. Here, we show that the primary cilium of renal epithelial cells contains a protein complex comprising adenylyl cyclase 5/6 (AC5/6), A-kinase anchoring protein 150 (AKAP150), and protein kinase A. Loss of primary cilia caused by deletion of Kif3a results in activation of AC5 and increased cAMP levels. Polycystin-2 (PC2), a ciliary calcium channel that is mutated in human PKD, interacts with AC5/6 through its C terminus. Deletion of PC2 increases cAMP levels, which can be corrected by reexpression of wild-type PC2 but not by a mutant lacking calcium channel activity. Phosphodiesterase 4C (PDE4C), which catabolizes cAMP, is also located in renal primary cilia and interacts with the AKAP150 complex. Expression of PDE4C is regulated by the transcription factor hepatocyte nuclear factor-1β (HNF-1β), mutations of which produce kidney cysts. PDE4C is down-regulated and cAMP levels are increased in HNF-1β mutant kidney cells and mice. Collectively, these findings identify PC2 and PDE4C as unique components of an AKAP complex in primary cilia and reveal a common mechanism for dysregulation of cAMP signaling in cystic kidney diseases arising from different gene mutations.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21670265      PMCID: PMC3127890          DOI: 10.1073/pnas.1016214108

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  33 in total

Review 1.  A physiological view of the primary cilium.

Authors:  Helle A Praetorius; Kenneth R Spring
Journal:  Annu Rev Physiol       Date:  2005       Impact factor: 19.318

2.  Kidney-specific inactivation of the KIF3A subunit of kinesin-II inhibits renal ciliogenesis and produces polycystic kidney disease.

Authors:  Fangming Lin; Thomas Hiesberger; Kimberly Cordes; Angus M Sinclair; Lawrence S B Goldstein; Stefan Somlo; Peter Igarashi
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-02       Impact factor: 11.205

3.  [Ca2+]i reduction increases cellular proliferation and apoptosis in vascular smooth muscle cells: relevance to the ADPKD phenotype.

Authors:  Sertac N Kip; Larry W Hunter; Qun Ren; Peter C Harris; Stefan Somlo; Vicente E Torres; Gary C Sieck; Qi Qian
Journal:  Circ Res       Date:  2005-03-24       Impact factor: 17.367

4.  PKD2 functions as an epidermal growth factor-activated plasma membrane channel.

Authors:  Rong Ma; Wei-Ping Li; Dana Rundle; Jin Kong; Hamid I Akbarali; Leonidas Tsiokas
Journal:  Mol Cell Biol       Date:  2005-09       Impact factor: 4.272

Review 5.  Roles of HNF-1beta in kidney development and congenital cystic diseases.

Authors:  Peter Igarashi; Xinli Shao; Brian T McNally; Thomas Hiesberger
Journal:  Kidney Int       Date:  2005-11       Impact factor: 10.612

6.  Inhibition of renal cystic disease development and progression by a vasopressin V2 receptor antagonist.

Authors:  Vincent H Gattone; Xiaofang Wang; Peter C Harris; Vicente E Torres
Journal:  Nat Med       Date:  2003-09-21       Impact factor: 53.440

7.  Polycystins 1 and 2 mediate mechanosensation in the primary cilium of kidney cells.

Authors:  Surya M Nauli; Francis J Alenghat; Ying Luo; Eric Williams; Peter Vassilev; Xiaogang Li; Andrew E H Elia; Weining Lu; Edward M Brown; Stephen J Quinn; Donald E Ingber; Jing Zhou
Journal:  Nat Genet       Date:  2003-01-06       Impact factor: 38.330

8.  Mutation of hepatocyte nuclear factor-1beta inhibits Pkhd1 gene expression and produces renal cysts in mice.

Authors:  Thomas Hiesberger; Yun Bai; Xinli Shao; Brian T McNally; Angus M Sinclair; Xin Tian; Stefan Somlo; Peter Igarashi
Journal:  J Clin Invest       Date:  2004-03       Impact factor: 14.808

9.  A transcriptional network in polycystic kidney disease.

Authors:  Lionel Gresh; Evelyne Fischer; Andreas Reimann; Myriam Tanguy; Serge Garbay; Xinli Shao; Thomas Hiesberger; Laurence Fiette; Peter Igarashi; Moshe Yaniv; Marco Pontoglio
Journal:  EMBO J       Date:  2004-03-18       Impact factor: 11.598

10.  Renal epithelial fluid secretion and cyst growth: the role of cyclic AMP.

Authors:  R Mangoo-Karim; M E Uchic; M Grant; W A Shumate; J P Calvet; C H Park; J J Grantham
Journal:  FASEB J       Date:  1989-12       Impact factor: 5.191

View more
  77 in total

1.  Altered trafficking and stability of polycystins underlie polycystic kidney disease.

Authors:  Yiqiang Cai; Sorin V Fedeles; Ke Dong; Georgia Anyatonwu; Tamehito Onoe; Michihiro Mitobe; Jian-Dong Gao; Dayne Okuhara; Xin Tian; Anna-Rachel Gallagher; Zhangui Tang; Xiaoli Xie; Maria D Lalioti; Ann-Hwee Lee; Barbara E Ehrlich; Stefan Somlo
Journal:  J Clin Invest       Date:  2014-11-03       Impact factor: 14.808

Review 2.  Planar cell polarity in kidney development and disease.

Authors:  Thomas J Carroll; Amrita Das
Journal:  Organogenesis       Date:  2011-07-01       Impact factor: 2.500

Review 3.  Advances in targeting cyclic nucleotide phosphodiesterases.

Authors:  Donald H Maurice; Hengming Ke; Faiyaz Ahmad; Yousheng Wang; Jay Chung; Vincent C Manganiello
Journal:  Nat Rev Drug Discov       Date:  2014-04       Impact factor: 84.694

Review 4.  Vasopressin and disruption of calcium signalling in polycystic kidney disease.

Authors:  Fouad T Chebib; Caroline R Sussman; Xiaofang Wang; Peter C Harris; Vicente E Torres
Journal:  Nat Rev Nephrol       Date:  2015-04-14       Impact factor: 28.314

Review 5.  The mechanisms of Hedgehog signalling and its roles in development and disease.

Authors:  James Briscoe; Pascal P Thérond
Journal:  Nat Rev Mol Cell Biol       Date:  2013-05-30       Impact factor: 94.444

Review 6.  Molecular pathways and therapies in autosomal-dominant polycystic kidney disease.

Authors:  Takamitsu Saigusa; P Darwin Bell
Journal:  Physiology (Bethesda)       Date:  2015-05

7.  Bardet-Biedl syndrome proteins 1 and 3 regulate the ciliary trafficking of polycystic kidney disease 1 protein.

Authors:  Xuefeng Su; Kaitlin Driscoll; Gang Yao; Anas Raed; Maoqing Wu; Philip L Beales; Jing Zhou
Journal:  Hum Mol Genet       Date:  2014-06-16       Impact factor: 6.150

8.  A cAMP and CREB-mediated feed-forward mechanism regulates GSK3β in polycystic kidney disease.

Authors:  Vijayakumar R Kakade; Shixin Tao; Madhumitha Rajagopal; Xia Zhou; Xiaogang Li; Alan S L Yu; James P Calvet; Pankaj Pandey; Reena Rao
Journal:  J Mol Cell Biol       Date:  2016-05-04       Impact factor: 6.216

9.  Phosphodiesterase Isoform Regulation of Cell Proliferation and Fluid Secretion in Autosomal Dominant Polycystic Kidney Disease.

Authors:  Cibele S Pinto; Archana Raman; Gail A Reif; Brenda S Magenheimer; Corey White; James P Calvet; Darren P Wallace
Journal:  J Am Soc Nephrol       Date:  2015-08-19       Impact factor: 10.121

10.  Disruption of polycystin-L causes hippocampal and thalamocortical hyperexcitability.

Authors:  Gang Yao; Chong Luo; Michael Harvey; Maoqing Wu; Taylor H Schreiber; Yanjun Du; Nuria Basora; Xuefeng Su; Diego Contreras; Jing Zhou
Journal:  Hum Mol Genet       Date:  2015-11-26       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.